Atractylenolide III, a bioactive component of Atractylodis Rhizoma, was reported to attenuate the transcriptional activity of NF-κB and to treat inflammation-related neurodegenerative diseases [36]. This evidence concerns the gene NFKB1 and neurodegenerative disease.